| Page 1732 | Kisaco Research
 

Paul Kemp

CEO
HairCLone

Paul Kemp

CEO
HairCLone

Paul Kemp

CEO
HairCLone
 

Louise Bisset

Biopharmaceutical Qaulity Assessor
MHRA

Louise Bisset

Biopharmaceutical Qaulity Assessor
MHRA

Louise Bisset

Biopharmaceutical Qaulity Assessor
MHRA
 

Lior Raviv

VP, Development & Operations
Pluristem

Lior Raviv

VP, Development & Operations
Pluristem

Lior Raviv

VP, Development & Operations
Pluristem
 

Liesbeth De Jong

Vice President, Manufacturing and R&D
Rexgenero

Liesbeth De Jong

Vice President, Manufacturing and R&D
Rexgenero

Liesbeth De Jong

Vice President, Manufacturing and R&D
Rexgenero
Phage Futures Europe - Poster Session
Sample Attendee List
 

Derek Hei

Chief of Manufacturing & Technical Operations
BlueRock Therapeutics

Derek Hei

Chief of Manufacturing & Technical Operations
BlueRock Therapeutics

Derek Hei

Chief of Manufacturing & Technical Operations
BlueRock Therapeutics
 

Andrew Spiegal

Executive Director
Global Colon Cancer Association

Andrew Spiegal

Executive Director
Global Colon Cancer Association

Andrew Spiegal

Executive Director
Global Colon Cancer Association
 

Prof. Dr.Dr.h.c. Thomas C. G. Bosch

Director, Zoological Institute
University Kiel

“Microbes as friends – insights from evolutionary biology”

Prof. Dr.Dr.h.c. Thomas C. G. Bosch

Director, Zoological Institute
University Kiel

Prof. Dr.Dr.h.c. Thomas C. G. Bosch

Director, Zoological Institute
University Kiel

“Microbes as friends – insights from evolutionary biology”

 

Veronika Oudova

Co-founder S-Biomedic

Direct modulation of the skin microbiome, S-Biomedic’s approach of addressing skin health.

 

Veronika Oudova

Co-founder S-Biomedic

Veronika Oudova

Co-founder S-Biomedic

Direct modulation of the skin microbiome, S-Biomedic’s approach of addressing skin health.